Mantle cell lymphoma trials in Australia

In Australia 13 Also abroad 150

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Where
Adelaide, Richmond, Waratah
Age
18 years and over
People
182 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06084936
Phase 1Taking people
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Where
Melbourne, VIC, Nedlands
Age
18 years and over
People
215 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00
Phase 1Taking people
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Where
Adelaide, Hobart, Perth, Westmead
Age
18 years and over
People
140 worldwide
Run by
Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Clayton, Melbourne, Nedlands, Southport
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Where
Birtinya, Box Hill, Clayton, Cooloongup, West Perth
Age
18 years and over
People
300 worldwide
Run by
BeOne Medicines
See details and how to joinNCT06742996 · EU 2024-515593-27-00
Phase 1/2Taking people
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Where
Heidelberg, Melbourne, Nedlands
Age
18 years and over
People
408 worldwide
Run by
AstraZeneca
See details and how to joinNCT06564038 · EU 2024-515034-33-00
Phase 1/2Taking people
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Where
Adelaide, Blacktown, Cooloongup, Malvern, Melbourne, Nedlands
Age
18 years and over
People
258 worldwide
Run by
BeOne Medicines
See details and how to joinNCT06697184 · EU 2024-518829-15-00
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Concord, Fitzroy, Heidelberg, Melbourne, Nedlands, Waratah, West Perth, Woolloongabba
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 1/2Taking people
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Where
Melbourne, Nedlands
Age
18 years and over
People
174 worldwide
Run by
AstraZeneca
See details and how to joinNCT06542250
Phase 1Taking people
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Where
Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
Age
18 years and over
People
168 worldwide
Run by
OncoNano Medicine, Inc.
See details and how to joinNCT06022029
Phase 1/2Taking people
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Where
Camperdown, Melbourne, Nedlands
Age
18 years and over
People
120 worldwide
Run by
CRISPR Therapeutics AG
See details and how to joinNCT05643742
Phase 1Taking people
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Where
Clayton
Age
18 years and over
People
32 worldwide
Run by
PharmaEngine
See details and how to joinNCT05659732
Phase 2Taking people
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Where
Nedlands, Parkville
Age
18 years and over
People
42
Run by
Australasian Leukaemia and Lymphoma Group
See details and how to joinNCT05833763